LEADER 01741nas 2200469-a 450 001 9910896081303321 005 20240911213022.0 035 $a(DE-599)ZDB2782722-7 035 $a(CKB)110978984251452 035 $a(CONSER)---96649750- 035 $a(EXLCZ)99110978984251452 100 $a19890712b198u2000 --- a 101 0 $aeng 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aFamily science review $eFSR 210 $aColumbus, OH $cDept. of Family Relations and Human Development, Ohio State University 215 $a1 online resource 300 $aRefereed/Peer-reviewed 300 $aPublished: DeKalb, IL : Dept. of Human & Family Resources, Northern Illinois University, <1994-> 311 08$aPrint version: Family science review : 1084-0524 (DLC) 96649750 (OCoLC)19996383 517 3 $aFSR 531 0 $aFam. sci. rev. 606 $aFamilies$xStudy and teaching$vPeriodicals 606 $aFamily life education$vPeriodicals 606 $aFamilies$xStudy and teaching$2fast$3(OCoLC)fst01728948 606 $aFamily life education$2fast$3(OCoLC)fst00920371 608 $aPeriodicals.$2fast 615 0$aFamilies$xStudy and teaching 615 0$aFamily life education 615 7$aFamilies$xStudy and teaching. 615 7$aFamily life education. 676 $a306.85/071 712 02$aOhio State University.$bDepartment of Family Relations and Human Development. 712 02$aFamily Science Association. 712 02$aNorthern Illinois University.$bDepartment of Human and Family Resources. 906 $aJOURNAL 912 $a9910896081303321 920 $aexl_impl conversion 996 $aFamily science review$92035326 997 $aUNINA LEADER 05474nam 2200685 a 450 001 9911019781803321 005 20200520144314.0 010 $a9786613679369 010 $a9781280768590 010 $a1280768592 010 $a9780470719206 010 $a0470719206 010 $a9780470716717 010 $a0470716711 035 $a(CKB)1000000000687620 035 $a(EBL)703766 035 $a(SSID)ssj0000715101 035 $a(PQKBManifestationID)11410193 035 $a(PQKBTitleCode)TC0000715101 035 $a(PQKBWorkID)10701285 035 $a(PQKB)11568008 035 $a(MiAaPQ)EBC703766 035 $a(OCoLC)264615452 035 $a(Perlego)2750390 035 $a(EXLCZ)991000000000687620 100 $a19850814h19611960 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCiba Foundation Symposium jointly with Committee for Symposia on Drug Action, on Adrenergic Mechanisms /$feditor for the British Pharmacological Society, J.R. Vane ; editors for the Ciba Foundation, G.E.W. Wolstenholme and Maeve O'Connor 210 $aBoston $cLittle, Brown and Co.$d[1961? c1960] 215 $a1 online resource (666 p.) 225 1 $aCiba Foundation symposia 300 $aDescription based upon print version of record. 311 08$a9780470722640 311 08$a0470722649 320 $aIncludes bibliographical references and indexes. 327 $aADRENERGIC MECHANISMS; CONTENTS; Opening address; Session 1 : Formafion and lnactivation of Adrenergic Transmitters; Formation of adrenergic transmitters; Formation of adrenaline and noradrenaline; Discussion; The fate of adrenaline and noradrenaline; 3-Methoxy-4-hydroxymandelic acid excretion in phaeochromocytoma; The metabolism of [?-l4CJ](±)-adrenaline in the cat; Discussion; Session 2: Storage of Catechol Aminer; Chairman's opening remarks; Origin, development and distribution of chromaffin cells; The storage of amines in the chromaffin cell 327 $aSome observations on the synthesis and storage of catechol amines in the adrenaline-containing cells of the suprarenal medullaCell types of the adrenal medulla; Discussion; Session 3: The Adrenergic Neurone; Chairman's opening remarks; Release of sympathetic transmitter by nerve stimulation; Discussion; Interference with the release of transmitter in response to nerve stimulation; The effects of bretylium and allied agents on adrenergic neurones; The persistence of adrenergic nerve conduction after TM 10 or bretylium in the cat; Some pharmacological properties of guanethidine; Discussion 327 $aSession 4: Adrenergic Mechanisms in ManEffects of adrenaline, noradrenaline and isopropylnoradrenaline in man; Effects of catechol amines on consecutive vascular sections; Discussion; Clinical effects of drugs which prevent the release of adrenergic transmitter; Bretylium; Discussion; Session 5 : Actions of Adrenaline and Noradrenaline on the Effector Cell; Chairman's opening remarks: The concept of receptors; Relationships between agonists, antagonists and receptor sites; Receptors for sympathomimetic amines; Sympathomimetic drugs and their receptors 327 $aVarious types of receptors for sympathomimetic drugsDiscussion; Biophysical changes produced by adrenaline and noradrenaline; Effect of adrenaline on depolarized smooth muscle; Discussion; The relation of adenosine-3',5'-phosphate to the action of catechol amines; The action of adrenaline on carbohydrate metabolism in relation to some of its pharmacodynamic efficts; Discussion; Session 6: Mechanism of Action of Other Sympathortiimetic Amines; Chairman's opening remarks; Tyramine and other amines as noradrenaline-releasing substances; Some observations on the effects of tyramine; Discussion 327 $aThe actions of sympathomimetic amines on tryptamine receptorsThe depolarizing and blocking action of amphetamine in the cat's superior cervical ganglion; Discussion; Session 7: Central Adrenergic Mechanisms; Chairman's opening remarks; Some central actions of adrenaline and noradrenaline when administered into the cerebral ventricles; Intervention of an adrenergic mechanism during brain stem reticular activation; Electrophysiological evidence relating to the ro?le of adrenaline in the central nervous system; The passage of catechol amines through the blood-brain barrier 327 $aRelease of an adrenaline-like substance by electrical stimulation of the brain stem 330 8 $aThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. 410 0$aCiba Foundation symposium. 606 $aAdrenergic mechanisms$vCongresses 615 0$aAdrenergic mechanisms 676 $a612.45082 701 $aVane$b John R$095892 701 $aO'Conner$b Maeve$01275287 701 $aWolstenholme$b G. E. W$g(Gordon Ethelbert Ward)$063039 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911019781803321 996 $aCiba Foundation Symposium jointly with Committee for Symposia on Drug Action, on Adrenergic Mechanisms$93005068 997 $aUNINA